Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > Crossing Over

April 6th, 2007

Crossing Over

Abstract:
Microarrays have also made the transition from the drug discovery market to point-of-care application. Researchers typically apply microarrays to genotyping, mutation screening, gene expression, and protein-interaction studies.

Typically microarrays provide ever more information per experiment. In the drug discovery arena, researchers use microarrays to perform large-scale studies in larger populations than ever before, providing a more comprehensive view of the human genetic variations that cause common diseases.

Source:
dddmag.com

Bookmark:

Related News Press

Nanomedicine

Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013

Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013

Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013

European Technology Platform for Nanomedicine and Nanomed2020 European Consortium Launch the Nanomedicine Award June 17th, 2013

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals

Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013

New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013

Working backward: Computer-aided design of zeolite templates: Rice scientists apply drug-design lessons to production of industrial minerals June 17th, 2013

An Innovative material for the Green Earth: Simple and inexpensive process to make a material for CO2 adsorption June 17th, 2013